The Innovation and Business Development Unit of IDIBELL participates in the largest congress of biotechnology industries in Europe

NO103 - BioEurope_Innov - Imatge

The Innovation and Business Development Area of ​​IDIBELL has attended the BIO-Europe Digital 2021 meeting. This is the most important event of the biotechnology, pharmaceutical, and financial industry specialized in life sciences in Europe. BIO-Europe attracts a wide range of business leaders, including leading executives from biotech companies, business development teams, investors, and other industry experts.

During the congress, which was held from October 25 to 28, IDIBELL representatives attended 63 meetings with 43 pharmaceutical companies, eight venture capital companies, six delegates, and six scientific experts. “We hope to take advantage of the momentum that we have just created during BIO-Europe to continue collaborating and growing during 2022“, concludes the Innovation and Business Development Area.

Generating agreements and connecting with colleagues in the sector continues to be an important part of creating successful projects. According to the organizers, this edition of BIO-Europe was four intense days with the participation of 2,941 delegates from 1,686 companies representing 55 countries who participated in more than 15,000 meetings.

In 2022 BIO-Europe will take place in face-to-face format and will take place in Leipzig, Germany, on the next 24-26 October. This will be the first face-to-face session since 2019. Important.



The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.

IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).

Scroll to Top